Hot Reads: 'ARK On Steroids'

Plus, UBS, Fidelity and State Street consider offering crypto exposure abroad.

ETF.com
|
Reviewed by: etf.com Staff
,
Edited by: etf.com Staff

Compiled by ETF.com Staff

 

Crypto Fund Popularity Sparks Manager Interest Abroad (Financial Times)

Fidelity, UBS and SSgA are looking at offering crypto exposure for clients outside of the U.S.

 

Cathie Wood Considering ‘ARK On Steroids’ Strategy (CNBC)

The fund manager is internally testing a strategy that combines the disruptive technology thesis while betting against major stocks.

 

Powell’s Historic Bet: Shrugging Off Inflation To Deliver Jobs (Politico)

Patience in the face of inflation is a new look for the Fed.

 

No Easy Answers For This Risk (Institutional Investor)

Investors are turning to hedges like real assets to protect against potential long-term inflation.

 

What To Watch As Flows Approach End Of Record Year (CNBC)

What to watch for the rest of 2021.

 

Will Crypto Protect Against Inflation? (Morningstar)

Why that common claim might be wrong.

 

Anti-ARKK ETF Shines (FA Magazine)

Spiking yields are dragging down expensive tech stocks.

 

Bitcoin’s Headed To $120K & That’s Just The Sideshow (Institutional Investor)

Cryptocurrencies continue to battle volatility and vocal critics, but BCA Research says they’re here to stay.

etf.com is the single source for ETF intelligence. We provide real-time ETF news and analysis to educate investors and drive financial knowledge in the space. Our personalized and accurate information, alongside industry-leading financial tools, are depended upon to develop winning investment and financial decisions. At etf.com, we strive to serve both the individual investor as well as the professional financial advisor to educate and grow the ETF community.